One of the scarier thoughts this Halloween is the state of the insulin pump market. As it stands today we have three players – market leader Medtronic (NYSE: MDT) who by our estimates will control almost 90% of the market – Insulet (NASDAQ: PODD) and Tandem (NASDAQ: TNDM). Given the way things are going at Tandem it won’t be long before the insulin pump market becomes the domain of just Medtronic and Insulet.
Yes, Bigfoot is still here but they are still a few years away from bringing their system to market. And yes, there are a host of insulin pump . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.